The week in health tech, explained in plain English.Get the free newsletter →
October 27, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Trump's 'Kill the Clipboard' Push Hasn't Ended Paperwork Yet

Last summer President Donald Trump stood at the White House and promised patients would soon be able to "kill the clipboard": no more filling out the same forms at every appointment and no more chasing records between doctors. CMS folded the pledge into what it calls the Health Technology Ecosystem, a voluntary framework meant to make patient data flow smoothly between apps, providers, and payers, according to Becker's Hospital Review.

In practice, the clipboard is still here. The initiative leans on tech companies and health systems opting in, and building shared standards for identity, records exchange, and patient-facing apps takes time. Progress depends on whether major EHR vendors and providers actually adopt the tools rather than treat participation as optional.

For executives, the signal is that Washington is again prioritizing interoperability and consumer access, echoing years of prior federal efforts. The open question is execution: whether voluntary commitments translate into real data portability, or whether patients keep re-entering the same information indefinitely.

More in Government

Government

Medicare Rule Could Cut Remote Patient Monitoring Access

A proposed CMS rule could sharply reduce Medicare reimbursement for remote patient monitoring, threatening access for rural and chronically ill patients.

Why it matters: Remote monitoring has become a fast-growing, loosely overseen Medicare service, and changing how it pays could reshape home-based care for millions.

Government

HHS Launches National Plan to Overhaul US Kidney Care

HHS launched a national kidney care plan centered on prevention, dialysis reform with more patient choice, and overhauling the transplant system.

Why it matters: Kidney disease affects 1 in 7 US adults and drives major Medicare spending, so federal direction here reshapes care models and markets.

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.